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An influx of immigrants is contributing to the reemergence 
of Plasmodium vivax malaria in Greece; 1 persistent focus 
of transmission is in Laconia, Pelopónnese. We genotyped 
archived blood samples from a substantial proportion of ma-
laria cases recorded in Greece in 2009–2013 using 8 micro-
satellite markers and a PvMSP-3α gene fragment and plot-
ted their spatiotemporal distribution. High parasite genetic 
diversity with low multiplicity of infection was observed. A 
subset of genetically identical/related parasites was re-
stricted to 3 areas in migrants and Greek residents, with 
some persisting over 2 consecutive transmission periods. 
We identified 2 hitherto unsuspected additional foci of local 
transmission: Kardhítsa and Attica. Furthermore, this anal-
ysis indicates that several cases in migrants initially clas-
sified as imported malaria were actually locally acquired. 
This study shows the potential for P. vivax to reestablish 
transmission and counsels public health authorities about 
the need for vigilance to achieve or maintain sustainable 
malaria elimination.
The global strategies for malaria control and elimination have led to substantial decreases in malaria incidence 
worldwide (1). In countries outside of Africa, Plasmodium 
vivax often predominates, making this species the most 
widespread malaria parasite. A combination of P. vivax bi-
ologic characteristics hamper its elimination and facilitate 
its reintroduction. The hypnozoite (i.e., the parasite during 
the dormant liver stage) can activate after months and 
cause new episodes, extending the period of carriage and 
transmission. The wide range of anopheline vectors that 
are susceptible to P. vivax and the capability of sporozo-
ites to mature in lower temperatures extends this parasite’s 
geographic range. Also, compared with P. falciparum, P. 
vivax infections have low peak parasitemias and clini-
cal immunity (protection against clinical manifestations) 
is rapidly acquired, resulting in infections that are often 
asymptomatic, which can prevent prompt diagnosis and 
treatment and prolong the duration of infection (2).
Episodes of rapid resurgence of P. vivax malaria have 
occurred as a consequence of substantial disruption of pub-
lic health services and large-scale population displacement 
triggered by war, civil unrest, or socioeconomic crises 
(3,4). In addition, with the increase in international travel 
and migration, sporadic cases of autochthonous infections 
due to transmission from carriers are noted yearly in vari-
ous nonendemic countries (5). In South Korea (declared 
malaria-free in 1979), reintroduction of P. vivax malaria 
followed by sustained transmission was observed. Start-
ing with a few cases recorded in the early 1990s in mili-
tary personnel posted at the demilitarized zone that bisects 
the Korean Peninsula, the numbers increased to a peak of 
≈4,100 by year 2000, with soldiers, veterans, and civil-
ians nearby the demilitarized zone equally affected (6). In-
fected mosquitoes from North Korea were responsible for 
the introduction of P. vivax and probably still contribute 
to transmission (7).
During 2009–2012, episodes of reintroduced autoch-
thonous P. vivax malaria occurred in Greece, the first 
such episodes in Europe since the 1970s. Greece was hy-
perendemic for malaria before an intense malaria eradi-
cation program (in 1946–1960), which led to the country 
becoming malaria-free in 1974, with a small number of 
imported malaria cases recorded annually thereafter (8). 
A threat to Greece’s malaria-free status arose with a ma-
jor upsurge in the number of undocumented migrants from 
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P. vivax–endemic countries, principally the Indian subcon-
tinent (estimated 200,000 migrants during 2006–2012) (9). 
During 2009–2013, nearly one fourth (27/113) of migrants 
with imported cases of P. vivax malaria reported a history 
of malaria in their country of origin (C. Hadjichristodou-
lou, unpub. data). The Hellenic Center for Disease Con-
trol and Prevention (HCDCP; Athens, Greece) declared 
these 113 cases as imported malaria (defined as occurring 
in persons arriving from endemic areas). HCDCP also de-
fined P. vivax cases occurring in migrants <3 years after 
their arrival to Greece as relapses (recrudescence from 
persistent subpatent blood infections [i.e., P. vivax infec-
tions in which the pathogen is present but not detectable 
by standard laboratory methods] was considered unlikely, 
although it could not be formally excluded). The poten-
tial for local transmission increased substantially in recep-
tive rural areas where migrants settled to serve as seasonal 
agricultural workers, thereby bringing carriers in contact 
with the local anopheline vectors during the transmission 
season. Of note, vector control activities after 1974 (after 
Greece was declared malaria-free) were not focused on 
Anopheles mosquitoes but rather on those that were con-
sidered a nuisance to the local population.
In 2009, an initial cluster of P. vivax malaria in 6 Greece 
residents (defined here as persons living in Greece with no 
travel history to P. vivax malaria–endemic areas) in a small 
agricultural locality in southern Pelopónnese (regional unit 
Laconia, municipality Evrótas) alerted the HCDCP. Only 
1 such locally acquired (autochthonous) case was reported 
in Evrótas in 2010 (10,11), but in 2011, a further 36 locally 
acquired cases in Greece residents and 21 cases classified 
as imported in migrant workers were recorded in the same 
area; these 57 cases represented ≈60% of all cases recorded 
in Greece that year. Despite prompt deployment of clas-
sic malaria prevention measures (mosquito control, distri-
bution of insecticide-treated bed nets, fever screening of 
immigrants, and investigation of each malaria case) during 
the 2011 and 2012 transmission seasons, 27 more cases (17 
imported in migrants and 10 in Greece residents) occurred 
in Evrótas in 2012. The next year, the same measures were 
reinforced by the deployment of mass drug administration 
targeting the migrant workers in the area (12), a strategy 
that seemed to have contributed to successfully thwarting 
the reestablishment of the parasite, considering that no au-
tochthonous cases were recorded from this regional unit in 
2013 and 2014. During the same period (2009–2013), 74 
imported P. falciparum cases were recorded in Greece, but 
none were in Laconia.
In another area, a village in regional unit Kardhítsa, 
Thessalía, 11 P. vivax malaria cases (2 locally acquired 
in Greek residents and 9 in migrants) were recorded in 
2012. In addition, 1 locally acquired case was recorded 
in 2013.
The availability of archived blood samples from a 
substantial proportion of all the P. vivax malaria cases re-
corded in Greece during 2009–2013, including those from 
Laconia, provided the opportunity to investigate in detail 
the spatiotemporal distribution of P. vivax introduction 
during this period through a molecular description of select 
parasite polymorphic genetic markers (13). Here we report 
on the spatiotemporal genotypic data from these cases and 
discuss the insights the data provide on the potential for 
P. vivax to establish sustained transmission in vulnerable 
receptive areas.
Materials and Methods
P. vivax Blood Samples
During 2009–2013, a total of 311 malaria cases were re-
ported to the HCDCP, of which 209 were caused by P. 
vivax as confirmed by microscopy or PCR analysis. All 
cases were symptomatic and recorded either through the 
passive surveillance system (hospitals, health centers) or 
through active surveillance activities, which included focus 
investigations of autochthonous cases and fever screening 
among immigrants in Laconia (12). Of the 209 recorded P. 
vivax cases, 122 blood samples collected from 118 patients 
were available for genotyping (Figure 1). Of the 53 Greece 
residents, 4 were Romanian, 4 were Moroccan, and 1 was 
Polish. The study protocol was approved with a waiver of 
informed consent by the Scientific Committee of the Post-
graduate Program of Applied Public Health and Environ-
mental Hygiene, Faculty of Medicine, University of Thes-
saly, Larissa, Greece.
Genomic DNA Isolation
We isolated genomic DNA from blood samples using the 
QIAamp DNA Mini Kit (QIAGEN GmbH, Hilden, Ger-
many), the Magcore automated system (RBC Bioscience, 
New Taipei City, Taiwan), or iPrep PureLink gDNA Blood 
Kit (Invitrogen, Carlsbad, CA, USA). The last method was 
used exclusively for the samples collected late in 2012 and 
in 2013.
Genotyping Analysis
We subjected P. vivax populations to genotyping targeting 
9 main polymorphic markers: 8 microsatellite loci and a 
region of the gene encoding PvMSP-3α. We pooled data 
available from a previous study for a subset of the samples 
(genotyped for a subset of markers) with the data we ob-
tained using additional samples and microsatellite mark-
ers (13). We performed genotyping for PvMSP-3α and 
microsatellite loci m1501 and m3502 as previously de-
scribed (13) and for microsatellite loci MS1, MS5, MS7, 
MS8, MS12, and MS20 as previously described (14). For 
a subset of samples (n = 54) that yielded similar or closely 
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related haplotypes, we performed genotyping for 4 addi-
tional polymorphic markers (3 microsatellite loci MS10, 
MS16, and Pv3.27, and the polymorphic F3 domain of 
PvMSP1), which are hereafter referred to as additional 
markers, as previously described (15). For all microsatel-
lite markers, we analyzed PCR products by capillary elec-
trophoresis using 500 LIZ or 1200 LIZ (Applied Biosys-
tems, Foster City, CA, USA) as size standards. We used 
GeneMarker 2.6.0 (https://www.softgenetics.com/Gen-
eMarker_4.php) for allele calling and considered peaks 
<500 relative fluorescence units noise. We checked sam-
ples manually to confirm true alleles.
We excluded samples from further analysis if <7 of 
the initial 9 genetic markers did not yield valid results. We 
classified a sample as having multiple genotype infections 
if >1 allelic variant with a peak height of at least a third of 
the main allelic variant peak was observed or, for PvMSP-
3α, if >1 DNA band was visible in the PCR products. We 
considered 2 haplotypes the same only when all 9 markers 
shared the same allelic variant. In cases of mixed genotype 
infections, the dominant allelic variant for each marker was 
alone considered to determine the haplotype. We used the 
term family to denote parasites that shared >7 out of the 9 
main markers. We constructed the phylogenetic tree using 
Populations 1.2.31 (http://bioinformatics.org/populations/) 
using the shared allele distance and UPGMA algorithm and 
visualized with Dendroscope 3 (16).
Results
Of the 122 samples, we genotyped 104 successfully; 14 
had 1 or 2 of the 9 markers fail to amplify, and 4 were ex-
cluded because <7 markers amplified. These 118 samples 
were obtained from 114 separate patients (4 patients had P. 
vivax infection and were tested in 2011 and 2012). This set 
comprised a substantial proportion of all the P. vivax cases 
recorded during 2009–2013 (Table). The samples were di-
vided into 3 subsets by their geographic location (Figure 
1): the first 2, Laconia (with 68 samples) and Kardhítsa 
(with 12 samples), were foci of transmission where mul-
tiple cases were recorded over time in a relatively restricted 
area, and the third encompassed the samples from the rest 
of Greece (with 38 samples).
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Figure 1. Geographic origin 
of Plasmodium vivax cases 
analyzed, Greece, 2009–2013. 
The 2 foci of transmission are 
Laconia and Kardhítsa (in bold). 
Size of dots is proportional to 
number of cases. Samples from 
Attica were distributed widely 
throughout this large regional 
unit, which includes Athens. 
 
Table. Reported Plasmodium vivax malaria cases, Greece, 2009–2013 
Year of onset 
Laconia  Kardhítsa and rest of Greece 
Greece resident Migrant* Greece resident Migrant 
Cases Samples Cases Samples Cases Samples Cases Samples 
2009 6 4 2 0  1 0 11 0 
2010 1 0 1 1  3 0 23 0 
2011 34 19 23 11  6 5 14 3 
2012† 15‡ 15 18 17  10 9 39 29 
2013 0 0 1 1  4§ 3 8 1 
*Population includes 6 persons with a travel history to endemic countries. 
†Includes 5 relapse cases and samples: 3 Greece residents and 1 migrant in Laconia and 1 Greece resident in the rest of Greece. 
‡Includes 2 locally acquired cases attributed to the 2011 transmission period. 
§Includes 1 locally acquired case attributed to the 2012 transmission period. 
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The extent of allelic diversity observed differed for the 
main genetic markers (range 5–23 distinct variants/marker; 
online Technical Appendix 1 Tables 1–3, https://wwwnc.
cdc.gov/EID/article/24/3/17-0605-Techapp1.xlsx), and the 
corresponding allelic frequency distributions differed by 
collection site (Figure 2, panels A–I). Mixed clone infec-
tions were detected in 18 samples, in which only 2 allelic 
variants were observed; among these 36 variants, 27 were 
the same 2 variants (12 of 1 variant and 15 of the other). 
Thus, most P. vivax cases diagnosed in Greece appeared to 
harbor monoclonal infections.
A total of 67 distinct haplotypes were observed when 
all 9 genetic markers were considered (online Technical 
Appendix 1 Table 1), of which 53 were unequivocal and 
14 corresponded to samples in which 1 or 2 of the mark-
ers failed to amplify. Of the 68 samples from the Laconia 
outbreak, we observed 28 unique P. vivax haplotypes only 
once, and we detected only 1 of these haplotypes (family 
Greece 4 [Gr4]) in samples collected from another region 
of Greece. Fourteen of the haplotypes from Laconia (ob-
served in 51 of 68 samples) fell into 4 families: 1) family 
Laconia 1 (La1), which was observed in 4 samples col-
lected in 2009; 2) La4, which had 8 subtypes and was ob-
served in 32 samples (24 of which were subtype La4–2); 
3) La5, which had 2 subtypes, each observed only once; 
and 4) La6, which had 3 subtypes observed in 13 samples 
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Figure 2. Frequency distribution of Plasmodium vivax allelic variants and lengths or subtype of genetic markers, by geographic location, 
Greece, 2009–2013. The frequencies for microsatellite markers MS1 (A), MS5 (B), MS7 (C), MS8 (D), MS12 (E), MS20 (F), m1501 (G), 
and m3502 (H) and gene fragment msp3 (I) are calculated separately for the samples from each of the 3 geographic sets: Laconia (n = 
68), Kardhítsa (n = 12), and the rest of Greece (n = 38).
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(11 of which were subtype La6–1). One fourth (17/68) of 
the samples from Laconia had unique haplotypes that did 
not belong to these 4 haplotype families. Of the 35 haplo-
types recorded outside Laconia, 1 haplotype of the fam-
ily Kardhítsa (Ka) was observed solely in the 12 samples 
(from 3 Greece residents and 9 migrants) in regional unit 
Kardhítsa. Two related haplotypes (of family Gr1) were 
observed in the same person who had a relapse in February 
2012 seven months after the first episode, and another 2 
haplotypes (Gr31 and Gr32, also related) were found in 2 
Greece residents from regional unit Évros who had symp-
toms 1 month apart from each other. Finally, 2 haplotypes 
of the Gr4 family were observed in 6 persons in the east of 
regional unit Attica (5 Greece residents and 1 migrant). The 
remaining 28 haplotypes were each observed only once in 
samples obtained throughout the rest of Greece (Figure 3; 
online Technical Appendix 2 Figures 1, 2, https://wwwnc.
cdc.gov/EID/article/24/3/17-0605-Techapp2.pdf).
To obtain a dynamic picture of the P. vivax isolates 
that were circulating in Greece throughout the episodes of 
reintroduction, we displayed the haplotypes in their order 
of temporal appearance (Figure 3). The dispersal pattern 
of P. vivax parasites, in particular those of the major hap-
lotype families (Gr4 in the eastern part of Attica; Ka in 
Kardhítsa; and La1, La4, La5, and La6 in Laconia), could 
be discerned. The genetic analysis of the parasites from La-
conia, the main focus of reintroduced P. vivax, showed that 
the parasite haplotype found in Greek residents in 2011 and 
2012, when most cases occurred, represented a restricted 
subset of the haplotypes found in the migrants. All but 3 of 
the samples acquired from 31 Greek residents (34 samples) 
belonged to 3 haplotype families: La4, La5, and La6. Fif-
teen of the 27 samples acquired from migrants during the 
same years also belonged to families La4–La6, with the re-
maining 12 samples from migrants each harboring a unique 
but unrelated parasite haplotype.
In Attica, 6 of the cases recorded during August 2011 
and summer 2012 among Greek residents from 4 differ-
ent locations were the same haplotype (Gr4); thus, Attica 
can be considered an additional focus of local transmission. 
We observed the same haplotype in an Afghani migrant 
who had P. vivax in early July 2012 in Laconia. Finally, in 
regional unit Kardhítsa, Thessalía, all 12 P. vivax samples 
(11 from 2012 and 1 from 2013) collected from a single 
village (6 of which were from a focus investigation) shared 
the same haplotype. Eleven of these samples were from pa-
tients of different nationalities (7 Afghani, 2 Bangladeshi, 
and 2 Romanian) who lived in close proximity and sought 
treatment within 2 months of each other.
Given that the differences between the haplotypes 
within each of these 6 families were minor, the correspond-
ing samples were subjected to genotyping with 4 additional 
genetic markers: 3 microsatellite loci MS10, MS16, and 
Pv3.27, and the polymorphic F3 domain of PvMSP1. This 
analysis revealed that the Gr4 family comprises 4 subtypes 
that differ with respect to 1 or 2 of the additional markers. 
We were able to distinguish 4 subtypes of haplotype family 
Ka and 3 subtypes of haplotype family La4 with 1 of these 
4 additional loci. The members of the La6 family were 
homogeneous at all these loci (online Technical Appendix 
2 Figures 1, 2).
Discussion
Using archived blood samples, we determined the genetic 
anatomy of many of the P. vivax isolates introduced into 
Greece during 2009–2013 and investigated the dynamics of 
the transition of a location from a source of imported cases 
to an area with established, sustained autochthonous trans-
mission. These transitions are increasingly likely to occur 
in areas where malaria control efforts have eliminated or 
will eliminate the parasite. This fact is of particular concern 
for P. vivax, whose ability to form hypnozoites substan-
tially enhances its potential to transmit over extended pe-
riods. Standard approaches of screening and treatment are 
inapplicable for P. vivax because screening for hypnozoite 
carriage is not possible. Moreover, the toxicity of prima-
quine phosphate, the only hypnozoitocidal drug available, 
precludes its use without prior onerous testing for glucose-
6-phosphate dehydrogenase deficiency. Thus, the often- 
asymptomatic or clinically mild relapses that might occur 
in migrants over time provide additional opportunities for 
local anopheline mosquitoes to transmit the parasite locally.
A total of 1,320 cases of malaria were reported in 
Greece during 1975–2008, a mean of 39 (range 16–79) 
cases/year; 475 of these cases were P. vivax diagnosed in 
visitors from the Indian subcontinent. Over this period only 
13 autochthonous cases (2 in 1975, 3 in 1976, 5 in 1991, 
1 in 1999, and 2 in 2000) occurred in diverse regions of 
Greece (8). In contrast, during 2009–2013, P. vivax ma-
laria was diagnosed in 139 migrants or travelers from en-
demic countries and 76 Greece residents (Table 1). Most 
likely, the substantial increase after 2006 in numbers of 
Indian subcontinent migrants, with many employed over 
the spring and summer months as agricultural workers, 
led to the reintroduction of P. vivax in some rural areas. 
The focus of introduced P. vivax malaria was considered 
to be in regional unit Laconia because 53 of the 76 cases in 
Greece residents were from 6 villages in Laconia (munici-
pality Evrótas) within a 2.5-km radius, with the remaining 
23 being from diverse and distant regions of Greece. The 
identification of the same haplotypes as in an earlier study, 
in which a combination of only 3 markers were used to 
analyze samples from 2 consecutive years (2011 and 2012), 
suggested that sustained transmission in the area was pos-
sible and further measures were needed to control the dis-
ease. Thus, mass drug administration with the immigrant 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 24, No. 3, March 2018 545
RESEARCH
population in Laconia was decided on and performed as a 
supplementary measure (12).
Our detailed spatiotemporal genetic analysis, in which 
we identified and compared the P. vivax haplotypes in pa-
tient samples, helped shed light on the epidemiology of 
reintroduced P. vivax episodes. Some of the infections in 
migrants in Laconia in 2011–2012 were most probably 
acquired locally and should consequently be reclassified 
as autochthonous. Careful analysis of the genotyping data 
uncovered 2 additional foci of local transmission and con-
firmed the need to reevaluate the classification of cases as 
autochthonous and imported. Despite the high number of 
cases, the focus in Attica was unsuspected because cases 
were scattered throughout the region. Genotyping revealed 
that parasites from 6 unrelated Greece residents (8 samples, 
2 in 2011 and 6 in 2012) living within a 15-km radius of 
each other shared the same haplotype (Gr4). This haplotype 
was also found in 2012 in 1 migrant living in Laconia, but 
further investigation did not reveal any epidemiologic con-
nection between this case and those from Attica.
The cluster of 11 cases recorded in 2011 in Kardhítsa 
was not thought of as a focus of local transmission because 
9 of these cases were in migrants from the Indian subconti-
nent. However, genotyping revealed that the parasites from 
all 11 migrants were of the same haplotype, as were those 
from a Greece resident with no history of malaria or travel 
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Figure 3. Temporal representation of the occurrence of Plasmodium vivax haplotypes, Greece, 2009–2013. Data for each region 
(Laconia, Kardhítsa, and rest of Greece) are depicted. Samples are indicated by shapes: in Laconia, squares indicate Greece residents 
and pentagons migrants; in Kardhítsa and rest of Greece, circles indicate Greece residents and hexagons migrants. Colors indicate 
haplotype families: La-1, yellow; La-4, blue; La-5, red; La-6, green; Gr-1, maroon; Gr-4, dark blue; and Ka, purple. Haplotype numbers 
are given inside shapes. The x-axis time scale for each year was stretched to accommodate the higher number of cases reported during 
the transmission season, with January, February, March, April, November, and December compressed. Lines joining 2 samples indicate 
isolates collected from the same person. Truncated vertical lines indicate the 3 samples collected in 2012 from persons considered 
exposed in the previous year: 1 relapse of a 2011 case and 2 patients with symptom onset in 2012 whose exposure was attributed to  
the 2011 transmission period. Dates of symptom onset of 2 patients tested in 2012 (green hexagons, haplotypes 28 and 29) were 
unknown and were arbitrarily assigned date August 1. Further details of samples are provided in online Technical Appendix 1 Tables 1–3  
(https://wwwnc.cdc.gov/EID/article/24/3/17-0605-Techapp1.xlsx).
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in 2013. This infection might have been acquired during 
the previous months from an asymptomatic carrier, or the 
infection might represent a delayed primary attack after in-
oculation by an infected mosquito the previous year. Thus, 
Kardhítsa represents a third focus of local transmission, 
where many of the migrant cases classified as imported 
malaria by using classic epidemiologic criteria should be 
reclassified as locally acquired.
From an epidemiologic point of view, P. vivax para-
sites have a high potential for initiating and maintaining 
local transmission within a short period of time from car-
riers reaching receptive areas hitherto free of malaria. In 
such areas, the nonimmune status of the local population 
will facilitate rapid detection of cases, considering that 
infected, previously malaria-naive residents would gener-
ally have clinical symptoms that are sometimes severe. 
However, in regions where P. vivax malaria has been 
eliminated or brought to very low incidence, the imported 
parasite strains might persist as subpatent infections be-
cause of residual levels of acquired immunity in the lo-
cal population, which would enhance the likelihood of 
wider dissemination. Nonetheless, data from the reintro-
duction episodes we present suggest that the potential for 
establishing transmission might differ by parasite strain, 
considering that relatively few P. vivax strains that were 
introduced into Greece during the 5 years of our analysis 
led to clusters of sustained local transmission. The differ-
ence in transmission might be attributable to biologic or 
environmental factors or a combination of both. The local 
mosquito populations might be inefficient at transmitting 
some of the imported strains (17), and variation in the vec-
tor midgut bacterial biota might also restrict transmission 
(18). However, the 3 foci we identified involved geneti-
cally diverse parasites (online Technical Appendix Fig-
ure 2), which could be explained by the parasites having 
differential transmission efficacies for the local anopheles 
populations. Finally, the degree of human–anopheline 
contact also plays a crucial role, such that the parasites 
in carriers residing in a rural area with a high mosquito 
density are more likely to be transmitted than parasites in 
carriers living in an urban environment with a low mos-
quito density.
The reintroduction of P. vivax malaria into Greece dur-
ing 2009–2013 should serve as a warning to those engaged 
in efforts to eliminate malaria (19) in countries where P. 
vivax predominates, especially for those in countries close 
to elimination and in malaria-free areas neighboring P. 
vivax–endemic regions. The prompt and flexible counter-
measures brought to bear by the Greek public health in-
frastructure were effective in containing and then extin-
guishing the foci of transmission (12). In our genotypic 
analyses, we highlight 2 epidemiologic features: first, the 
high potential for imported P. vivax to establish sustainable 
transmission within a short time; and second, the diffi-
culty in predicting the locations where such transmission 
might occur. P. vivax is a recognized obstacle for malaria 
elimination (20). Maintaining vigilance will be crucial to 
ensure that this parasite will not threaten those countries 
that achieve it.
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Technical Appendix Figure 1. Network phylogenetic analysis of the Plasmodium vivax isolates, Greece, 
2009–2013. The haplotype families are highlighted with different colors. Detailed description of the 
haplotypes is provided in online Technical Appendix 1 Tables 1–3 
(https://wwwnc.cdc.gov/EID/article/24/3/17-0605-Techapp1.xlsx). 
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Technical Appendix Figure 2. Phylogenetic tree of the Plasmodium vivax isolates, Greece, 2009–2013. 
The haplotype families are highlighted with different colors. Detailed description of the haplotypes is 
provided in the online Technical Appendix 1 Tables 1–3 (https://wwwnc.cdc.gov/EID/article/24/3/17-0605-
Techapp1.xlsx). 
